Merge Hemo software. Merge Hemo monitors, measures, and records physiologic data from a human patient undergoing a cardiac catheterization procedure
Published February 1, 2017 · Recall initiated: March 28, 2016
Summary
FDA records medical device Class II recall Z-1091-2017, published February 1, 2017 and initiated March 28, 2016. Recalling firm: Merge Healthcare, Inc.; Status: Terminated; Reported quantity: 242 sites potentially have the affected versions; Lot: Versions 6.10, 6.10.1, 6.10.2, 6.10.3, 7.10, 7.20, 7.20.1, 8.10.0, 8.20, 9.10.0, 9.20, 9.20.2, 9.20.3, 9.30, 9.40, 9.40.1, 9.40.2, and 9.40.3. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There is a potential connection issue when powering up the Merge Hemo Record Station and the Hemo Monitor does not communicate with the Client PC.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Merge Healthcare, Inc.
- Distributor
- Nationwide Distribution
- Lot
- Versions 6.10, 6.10.1, 6.10.2, 6.10.3, 7.10, 7.20, 7.20.1, 8.10.0, 8.20, 9.10.0, 9.20, 9.20.2, 9.20.3, 9.30, 9.40, 9.40.1, 9.40.2, and 9.40.3
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAMerge PACS and Merge OrthoPACS, medical imaging diagnostic workstationSeptember 2, 2026
- FDAMerge OrthoPACS, medical imaging diagnostic workstationAugust 12, 2026
- FDAMerge PACS, medical imaging diagnostic workstationAugust 12, 2026
- FDAVERICIS, Merge Cardio, Model/Catalog Number: Version 9.x, Software Version: 9.0.6 and 9.0.8; VERICIS is anMarch 26, 2025
- FDAcobas p 612 pre-analytical system; Pre-analytical sample handling that includes de-capping, Aliquotting andFebruary 1, 2017
- FDATina-Quant (Latex) HS Test System (C-Reactive Protein (Latex) High Sensitive) The Tina-Quant CRP (Latex) HighFebruary 1, 2017
Questions about this recall
Was Merge Hemo software. Merge Hemo monitors, measures, and records physiologic data from a human patient undergoing a cardiac catheterization procedure recalled?
Yes. FDA published recall Z-1091-2017 on February 1, 2017. Reported hazard: There is a potential connection issue when powering up the Merge Hemo Record Station and the Hemo Monitor does not communicate with the Client PC.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit